These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24205397)

  • 21. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.
    Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y
    J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular insights into primary hyperoxaluria type 1 pathogenesis.
    Cellini B; Oppici E; Paiardini A; Montioli R
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):621-34. PubMed ID: 22201765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular aetiology of primary hyperoxaluria and its implications for clinical management.
    Danpure CJ; Rumsby G
    Expert Rev Mol Med; 2004 Jan; 6(1):1-16. PubMed ID: 14987413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular aetiology of primary hyperoxaluria type 1.
    Danpure CJ
    Nephron Exp Nephrol; 2004; 98(2):e39-44. PubMed ID: 15499210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.
    Montioli R; Roncador A; Oppici E; Mandrile G; Giachino DF; Cellini B; Borri Voltattorni C
    Hum Mol Genet; 2014 Nov; 23(22):5998-6007. PubMed ID: 24990153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B
    Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
    Leiper JM; Oatey PB; Danpure CJ
    J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I.
    Roncador A; Oppici E; Talelli M; Pariente AN; Donini M; Dusi S; Voltattorni CB; Vicent MJ; Cellini B
    Nanomedicine; 2017 Apr; 13(3):897-907. PubMed ID: 27993722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
    Dindo M; Mandrile G; Conter C; Montone R; Giachino D; Pelle A; Costantini C; Cellini B
    Mol Genet Metab; 2020; 131(1-2):171-180. PubMed ID: 32792227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.
    Danpure CJ; Jennings PR; Fryer P; Purdue PE; Allsop J
    J Inherit Metab Dis; 1994; 17(4):487-99. PubMed ID: 7967498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.
    Gatticchi L; Dindo M; Pampalone G; Conter C; Cellini B; Takayama T
    Biochem Biophys Res Commun; 2023 Feb; 645():118-123. PubMed ID: 36682331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
    Danpure CJ; Jennings PR
    Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.
    Purdue PE; Takada Y; Danpure CJ
    J Cell Biol; 1990 Dec; 111(6 Pt 1):2341-51. PubMed ID: 1703535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrostatic interactions drive native-like aggregation of human alanine:glyoxylate aminostransferase.
    Dindo M; Conter C; Cellini B
    FEBS J; 2017 Nov; 284(21):3739-3764. PubMed ID: 28906061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
    Santana A; Salido E; Torres A; Shapiro LJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.
    Pey AL; Albert A; Salido E
    Biomed Res Int; 2013; 2013():687658. PubMed ID: 23956997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.